Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep;70(3):309-310.
doi: 10.1053/j.ajkd.2017.05.016.

After 4 Decades of Lupus Nephritis Trials, Is There a "Best" Therapy?

Affiliations
Editorial

After 4 Decades of Lupus Nephritis Trials, Is There a "Best" Therapy?

Andrew S Bomback. Am J Kidney Dis. 2017 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. Journal of the American Society of Nephrology : JASN. 2010;21(12):2028–2035. - PubMed
    1. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982–1995. Arch Intern Med. 2000;160(20):3136–3140. - PubMed
    1. Ward MM. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996–2004. J Rheumatol. 2009;36(1):63–67. - PMC - PubMed
    1. Palmer SC, Tunnicliffe DJ, Singh-Grewal D, et al. Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2017 - PubMed
    1. Bao H, Liu ZH, Xie HL, Hu WX, Zhang HT, Li LS. Successful treatment of class V+IV lupus nephritis with multitarget therapy. Journal of the American Society of Nephrology : JASN. 2008;19(10):2001–2010. - PMC - PubMed

Substances

LinkOut - more resources